Edward S Huang, MD
Gastroenterology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 7
Offices
7 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Huang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A94260 · Current
Licensed to practise in California · since 2006 · expires 2028-03-31 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$178,003
Medicare paid this office $178,003 for 637 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 184 | $42,567 | $230 |
| Return visit (30+ min) | 195 | $32,783 | $116 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 180 | $14,635 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $14,173 | $145 |
| Biopsy of large bowel using a flexible endoscope | 166 | $12,394 | $74 |
See all 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 184 | $42,567 | $230 |
| Return visit (30+ min) | 195 | $32,783 | $116 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 180 | $14,635 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $14,173 | $145 |
| Biopsy of large bowel using a flexible endoscope | 166 | $12,394 | $74 |
| Short return visit (20+ min) | 104 | $10,239 | $80 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $10,197 | $784 |
| New patient visit (45+ min) | 52 | $7,463 | $144 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 30 | $6,183 | $206 |
| Diagnostic exam of large bowel using a flexible endoscope | 38 | $6,055 | $155 |
| Diagnostic exam of anus using an endoscope | 24 | $2,905 | $121 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 16 | $2,841 | $114 |
| Long return visit (40+ min) | 13 | $2,252 | $173 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $203 | $14 |
Procedures Medicare counted
| Colonoscopy | 144 | More than 88% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 179 | More than 88% of doctors who do this |
Who their Medicare patients are
637 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 14% · Women 57% · Also on Medicaid 11% · Health risk score 1.16. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 71% · Diabetes 31% · Coronary heart disease 27% · Chronic kidney disease 21% · Atrial fibrillation 19% · Depression 19% · Cancer 16% · Heart failure 14% · COPD 13% · Dementia 9% · Stroke 9%.
The office billed $1,545,479, Medicare allowed $227,198 and paid $178,003; for 1,369 services of 46 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 637 | 1,369 | 76 | 1.16 | $1,545,479 | $178,003 |
| 2023 | 588 | 1,370 | 75 | 1.17 | $1,336,344 | $166,804 |
| 2022 | 637 | 1,475 | 75 | 1.10 | $1,389,874 | $182,146 |
| 2021 | 595 | 1,445 | 75 | 1.26 | $1,431,580 | $180,044 |
| 2020 | 478 | 1,242 | 75 | 1.37 | $1,111,374 | $134,827 |
| 2019 | 599 | 1,578 | 75 | 1.25 | $1,384,993 | $164,749 |
| 2018 | 480 | 1,311 | 75 | 1.26 | $1,028,617 | $120,034 |
| 2017 | 442 | 1,308 | 74 | 1.39 | $950,241 | $113,901 |
| 2016 | 366 | 899 | 74 | 1.19 | $777,144 | $106,062 |
| 2015 | 320 | 720 | 74 | 1.17 | $558,960 | $91,396 |
| 2014 | 238 | 628 | 74 | 1.15 | $398,773 | $69,177 |
| 2013 | 309 | 950 | 75 | 1.33 | $344,175 | $112,641 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 178 | $43,870 | $241 |
| Return visit (30+ min) | 197 | $31,569 | $112 |
| Short return visit (20+ min) | 129 | $12,569 | $83 |
| Biopsy of large bowel using a flexible endoscope | 154 | $11,791 | $76 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 132 | $11,263 | $80 |
| New patient visit (45+ min) | 67 | $9,726 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $8,889 | $146 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 32 | $6,750 | $211 |
| Diagnostic exam of large bowel using a flexible endoscope | 17 | $2,665 | $157 |
| Long return visit (40+ min) | 11 | $2,022 | $169 |
| Diagnostic exam of anus using an endoscope | 14 | $1,655 | $110 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 11 | $1,611 | $124 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,147 | $104 |
| New patient visit (30+ min) | 12 | $1,095 | $91 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 103 | $490 | $5 |
2022: 15 services
| Return visit (30+ min) | 263 | $47,111 | $117 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 183 | $42,912 | $232 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $13,345 | $180 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 145 | $13,212 | $89 |
| Imaging of digestive tract done from the inside of the digestive tract | 13 | $11,353 | $873 |
| Biopsy of large bowel using a flexible endoscope | 146 | $11,038 | $76 |
| New patient visit (45+ min) | 62 | $8,812 | $142 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 30 | $6,161 | $205 |
| Short return visit (20+ min) | 38 | $3,037 | $74 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,453 | $204 |
| Imaging of digestive tract done from the inside of the digestive tract | 15 | $1,714 | $107 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,657 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,428 | $65 |
| New patient visit (30+ min) | 17 | $1,361 | $80 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 158 | $800 | $5 |
2021: 18 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 185 | $43,453 | $232 |
| Return visit (30+ min) | 194 | $29,804 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $15,343 | $178 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 160 | $14,991 | $90 |
| Biopsy of large bowel using a flexible endoscope | 187 | $14,091 | $75 |
| Imaging of digestive tract done from the inside of the digestive tract | 14 | $13,552 | $968 |
| New patient visit (45+ min) | 69 | $10,773 | $156 |
| Short return visit (20+ min) | 68 | $5,895 | $78 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 23 | $4,980 | $217 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $3,183 | $152 |
| Long return visit (40+ min) | 12 | $2,131 | $164 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,630 | $125 |
| New patient visit (30+ min) | 16 | $1,502 | $94 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $1,452 | $121 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,406 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,129 | $66 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 156 | $797 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $193 | $15 |
2020: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 143 | $33,591 | $232 |
| Return visit (30+ min) | 143 | $20,852 | $99 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 130 | $11,676 | $87 |
| Biopsy of large bowel using a flexible endoscope | 150 | $10,797 | $72 |
| New patient visit (45+ min) | 62 | $8,569 | $138 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,419 | $185 |
| Short return visit (20+ min) | 79 | $5,865 | $65 |
| New patient visit (30+ min) | 30 | $2,825 | $94 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $2,812 | $104 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,245 | $118 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,201 | $200 |
| Long return visit (40+ min) | 11 | $1,574 | $143 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 131 | $683 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $212 | $15 |
2019: 19 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 146 | $31,892 | $213 |
| Return visit (30+ min) | 175 | $23,506 | $96 |
| Biopsy of large bowel using a flexible endoscope | 203 | $17,080 | $83 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 157 | $14,419 | $87 |
| Imaging of digestive tract done from the inside of the digestive tract | 14 | $13,327 | $888 |
| New patient visit (45+ min) | 80 | $11,540 | $144 |
| Removal of large bowel tissue using a flexible endoscope | 26 | $7,993 | $307 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,890 | $175 |
| Short return visit (20+ min) | 90 | $7,222 | $67 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,558 | $209 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,913 | $208 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $2,072 | $173 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,988 | $124 |
| New patient visit (30+ min) | 23 | $1,976 | $86 |
| Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen | 20 | $1,540 | $64 |
| Long return visit (40+ min) | 11 | $1,483 | $135 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,429 | $110 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 255 | $1,307 | $5 |
| Short return visit | 17 | $759 | $45 |
2018: 19 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 95 | $21,056 | $215 |
| Return visit (30+ min) | 159 | $19,979 | $91 |
| Biopsy of large bowel using a flexible endoscope | 147 | $14,375 | $95 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 120 | $11,628 | $95 |
| New patient visit (45+ min) | 45 | $6,574 | $146 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,941 | $176 |
| Short return visit (20+ min) | 62 | $3,921 | $61 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,610 | $201 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,254 | $191 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $3,085 | $119 |
| New patient visit (30+ min) | 32 | $2,581 | $81 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,906 | $159 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 216 | $1,079 | $5 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $958 | $87 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $951 | $34 |
| Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen | 11 | $832 | $64 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 64 | $817 | $11 |
| Biopsy of lower large bowel using a flexible endoscope | 11 | $551 | $50 |
| Injection beneath lining of large bowel using a flexible endoscope | 20 | $299 | $15 |
2017: 19 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 83 | $18,920 | $225 |
| Biopsy of large bowel using a flexible endoscope | 150 | $16,354 | $108 |
| Return visit (30+ min) | 106 | $12,038 | $88 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 120 | $10,810 | $85 |
| New patient visit (45+ min) | 68 | $9,047 | $133 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $8,744 | $165 |
| Short return visit (20+ min) | 74 | $5,268 | $60 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,190 | $199 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,885 | $206 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,723 | $118 |
| New patient visit (30+ min) | 35 | $2,722 | $78 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | $2,308 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,822 | $63 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 120 | $1,386 | $10 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $711 | $34 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 172 | $701 | $4 |
| Short return visit | 17 | $566 | $33 |
| Injection beneath lining of large bowel using a flexible endoscope | 18 | $446 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $402 | $11 |
2016: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 70 | $16,655 | $231 |
| Return visit (30+ min) | 126 | $16,144 | $91 |
| Biopsy of large bowel using a flexible endoscope | 121 | $12,932 | $104 |
| New patient visit (45+ min) | 78 | $10,777 | $138 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 104 | $10,011 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,571 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $4,096 | $63 |
| Short return visit (20+ min) | 59 | $3,931 | $61 |
| Diagnostic exam of large bowel using a flexible endoscope | 17 | $2,771 | $163 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,505 | $179 |
| New patient visit (30+ min) | 19 | $1,784 | $94 |
| Short return visit | 18 | $693 | $38 |
| Injection beneath lining of large bowel using a flexible endoscope | 15 | $570 | $38 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $513 | $34 |
2015: 12 services
| Return visit (30+ min) | 100 | $13,381 | $94 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 40 | $10,902 | $273 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 93 | $9,705 | $99 |
| Biopsy of large bowel using a flexible endoscope | 61 | $9,602 | $155 |
| New patient visit (45+ min) | 59 | $8,567 | $145 |
| Short return visit (20+ min) | 91 | $7,330 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,760 | $183 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,814 | $224 |
| New patient visit (30+ min) | 35 | $3,535 | $101 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,271 | $218 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,720 | $194 |
| Short return visit | 14 | $507 | $36 |
2014: 8 services
| Return visit (30+ min) | 109 | $18,525 | $90 |
| New patient visit (45+ min) | 56 | $8,092 | $145 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | $7,133 | $100 |
| Short return visit (20+ min) | 74 | $5,601 | $60 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 20 | $5,468 | $273 |
| Biopsy of large bowel using a flexible endoscope | 28 | $4,096 | $146 |
| New patient visit (30+ min) | 43 | $3,964 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,058 | $180 |
2013: 13 services
| Return visit (30+ min) | 188 | $34,570 | $93 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 84 | $14,554 | $140 |
| New patient visit (45+ min) | 64 | $9,409 | $147 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 30 | $7,932 | $264 |
| Biopsy of large bowel using a flexible endoscope | 36 | $6,816 | $179 |
| Short return visit (20+ min) | 81 | $6,227 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,258 | $175 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $4,080 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $3,708 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,190 | $63 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,773 | $118 |
| New patient visit (30+ min) | 11 | $1,092 | $99 |
| Stool analysis for blood to screen for colon tumors | 19 | $84 | $4 |
Drugs they prescribed that Part D paid
$537,247
Pharmacies billed $537,247 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,215 generic and 203 brand-name prescriptions · $537,247 in drug cost · 29 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 48 | $46,388 | $966 |
| Vemlidy | 13 | $18,844 | $1,450 |
| Mesalamine | 20 | $18,572 | $929 |
| Sod Sulf-Potass Sulf-Mag Sulf | 171 | $11,229 | $66 |
| Opium Tincture | 11 | $4,764 | $433 |
See all 21 drugs
| Linzess | 48 | $46,388 | $966 |
| Vemlidy | 13 | $18,844 | $1,450 |
| Mesalamine | 20 | $18,572 | $929 |
| Sod Sulf-Potass Sulf-Mag Sulf | 171 | $11,229 | $66 |
| Opium Tincture | 11 | $4,764 | $433 |
| Mesalamine Er | 14 | $4,675 | $334 |
| Pantoprazole | 210 | $3,381 | $16 |
| Omeprazole | 326 | $3,279 | $10 |
| Cholestyramine | 39 | $2,798 | $72 |
| Vancomycin | 15 | $1,782 | $119 |
| Famotidine | 109 | $1,737 | $16 |
| Tenofovir Disoproxil | 24 | $1,576 | $66 |
| Peg 3350-Electrolyte | 70 | $1,441 | $21 |
| Sucralfate | 18 | $1,285 | $71 |
| Esomeprazole Magnesium | 12 | $1,198 | $100 |
| Dicyclomine | 48 | $1,090 | $23 |
| Budesonide Dr | 15 | $823 | $55 |
| Azathioprine | 15 | $705 | $47 |
| Lactulose | 13 | $365 | $28 |
| Diphenoxylate-Atropine | 13 | $318 | $24 |
| Nortriptyline | 11 | $58 | $5 |
Year by year
| 2024 | 1,429 | 485 | None | 14% | $537,247 |
| 2023 | 1,332 | 487 | 0% (0) | 19% | $465,073 |
| 2022 | 1,222 | 468 | None | 27% | $263,760 |
| 2021 | 1,127 | 438 | None | 28% | $150,751 |
| 2020 | 961 | 337 | 0% (0) | 22% | $176,209 |
| 2019 | 870 | 385 | 0% (0) | 31% | $124,281 |
| 2018 | 801 | 319 | None | 32% | $124,963 |
| 2017 | 688 | 262 | None | None | $293,534 |
| 2016 | 663 | 240 | 0% (0) | None | $523,361 |
| 2015 | 538 | 193 | None | None | $302,149 |
| 2014 | 603 | 174 | None | None | $148,172 |
| 2013 | 942 | 237 | None | None | $93,352 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Linzess | 38 | $31,076 | $818 |
| Vemlidy | 17 | $24,942 | $1,467 |
| Mesalamine | 17 | $16,312 | $960 |
| Sod Sulf-Potass Sulf-Mag Sulf | 150 | $11,784 | $79 |
| Opium Tincture | 13 | $5,508 | $424 |
| Mesalamine Er | 15 | $4,492 | $299 |
| Omeprazole | 287 | $4,046 | $14 |
| Vancomycin | 16 | $3,364 | $210 |
| Pantoprazole | 131 | $3,152 | $24 |
| Peg 3350-Electrolyte | 130 | $2,777 | $21 |
| Sucralfate | 28 | $2,088 | $75 |
| Famotidine | 105 | $1,616 | $15 |
| Esomeprazole Magnesium | 12 | $1,447 | $121 |
| Tenofovir Disoproxil | 22 | $1,432 | $65 |
| Suprep | 12 | $1,406 | $117 |
| Cholestyramine | 14 | $1,311 | $94 |
| Budesonide Dr | 12 | $1,247 | $104 |
| Dicyclomine | 41 | $1,245 | $30 |
| Azathioprine | 15 | $1,039 | $69 |
| Diphenoxylate-Atropine | 22 | $578 | $26 |
| Lactulose | 13 | $481 | $37 |
| Propranolol | 16 | $475 | $30 |
| Lansoprazole | 11 | $430 | $39 |
| Ondansetron Odt | 14 | $156 | $11 |
2022: 24 drugs
| Vemlidy | 23 | $31,872 | $1,386 |
| Creon | 18 | $31,225 | $1,735 |
| Linzess | 42 | $29,279 | $697 |
| Mesalamine | 18 | $19,103 | $1,061 |
| Mesalamine Er | 26 | $14,603 | $562 |
| Suprep | 118 | $13,530 | $115 |
| Dexilant | 15 | $8,773 | $585 |
| Vancomycin | 28 | $7,167 | $256 |
| Symproic | 12 | $5,424 | $452 |
| Opium Tincture | 11 | $4,661 | $424 |
| Omeprazole | 261 | $4,470 | $17 |
| Pantoprazole | 120 | $2,440 | $20 |
| Sod Sulf-Potass Sulf-Mag Sulf | 26 | $2,092 | $80 |
| Esomeprazole Magnesium | 12 | $2,086 | $174 |
| Peg 3350-Electrolyte | 98 | $1,915 | $20 |
| Famotidine | 70 | $1,521 | $22 |
| Cholestyramine | 13 | $1,482 | $114 |
| Sucralfate | 23 | $1,276 | $55 |
| Tenofovir Disoproxil | 15 | $1,258 | $84 |
| Azathioprine | 15 | $1,104 | $74 |
| Dicyclomine | 34 | $1,074 | $32 |
| Diphenoxylate-Atropine | 15 | $765 | $51 |
| Ondansetron Odt | 16 | $455 | $28 |
| Gavilyte-C | 21 | $338 | $16 |
2021: 19 drugs
| Mesalamine Er | 38 | $19,001 | $500 |
| Suprep | 160 | $17,691 | $111 |
| Vancomycin | 39 | $11,089 | $284 |
| Mesalamine | 15 | $10,788 | $719 |
| Omeprazole | 292 | $4,648 | $16 |
| Pantoprazole | 116 | $3,052 | $26 |
| Cholestyramine | 11 | $2,412 | $219 |
| Famotidine | 55 | $1,507 | $27 |
| Budesonide Dr | 17 | $1,460 | $86 |
| Azathioprine | 13 | $1,011 | $78 |
| Tenofovir Disoproxil | 14 | $949 | $68 |
| Dextrose 5%-0.9% Nacl | 18 | $809 | $45 |
| Dicyclomine | 16 | $771 | $48 |
| Peg 3350-Electrolyte | 20 | $447 | $22 |
| Lansoprazole | 16 | $248 | $15 |
| Gavilyte-C | 17 | $224 | $13 |
| Furosemide | 13 | $176 | $14 |
| Peg-3350 and Electrolytes | 14 | $161 | $12 |
| Gavilyte-G | 14 | $152 | $11 |
2020: 18 drugs
| Mesalamine Er | 24 | $16,506 | $688 |
| Vancomycin | 30 | $13,219 | $441 |
| Suprep | 106 | $11,187 | $106 |
| Linzess | 14 | $9,928 | $709 |
| Opium Tincture | 11 | $4,147 | $377 |
| Sucralfate | 14 | $4,121 | $294 |
| Omeprazole | 230 | $3,803 | $17 |
| Pantoprazole | 114 | $2,970 | $26 |
| Esomeprazole Magnesium | 13 | $2,587 | $199 |
| Tenofovir Disoproxil | 18 | $1,664 | $92 |
| Famotidine | 52 | $1,542 | $30 |
| Propranolol | 13 | $700 | $54 |
| Dicyclomine | 22 | $610 | $28 |
| Lactulose | 11 | $414 | $38 |
| Peg 3350-Electrolyte | 25 | $379 | $15 |
| Gavilyte-C | 19 | $254 | $13 |
| Gavilyte-N | 20 | $233 | $12 |
| Nortriptyline | 12 | $123 | $10 |
2019: 19 drugs
| Vemlidy | 21 | $23,621 | $1,125 |
| Apriso | 15 | $15,845 | $1,056 |
| Suprep | 121 | $12,111 | $100 |
| Budesonide Ec | 17 | $9,301 | $547 |
| Dexilant | 16 | $7,862 | $491 |
| Amitiza | 14 | $7,444 | $532 |
| Vancomycin | 13 | $6,214 | $478 |
| Tenofovir Disoproxil | 19 | $2,683 | $141 |
| Omeprazole | 163 | $2,383 | $15 |
| Pantoprazole | 129 | $2,355 | $18 |
| Cholestyramine | 16 | $1,870 | $117 |
| Moviprep | 14 | $1,504 | $107 |
| Ranitidine | 62 | $799 | $13 |
| Propranolol | 12 | $535 | $45 |
| Gavilyte-C | 37 | $416 | $11 |
| Peg 3350-Electrolyte | 24 | $368 | $15 |
| Dicyclomine | 18 | $331 | $18 |
| Gavilyte-N | 14 | $234 | $17 |
| Peg 3350-Electrolyte | 17 | $159 | $9 |
2018: 14 drugs
| Vemlidy | 13 | $14,839 | $1,141 |
| Viread | 15 | $12,035 | $802 |
| Suprep | 111 | $10,580 | $95 |
| Apriso | 12 | $10,385 | $865 |
| Dexilant | 19 | $8,173 | $430 |
| Vancomycin | 18 | $5,763 | $320 |
| Omeprazole | 185 | $2,524 | $14 |
| Pantoprazole | 105 | $1,303 | $12 |
| Ranitidine | 50 | $814 | $16 |
| Peg 3350-Electrolyte | 47 | $757 | $16 |
| Polyethylene Glycol 3350 | 19 | $435 | $23 |
| Gavilyte-N | 19 | $344 | $18 |
| Ondansetron Odt | 15 | $234 | $16 |
| Dicyclomine | 11 | $171 | $16 |
2017: 14 drugs
| Pentasa | 13 | $15,722 | $1,209 |
| Viread | 14 | $14,485 | $1,035 |
| Dexilant | 24 | $7,412 | $309 |
| Suprep | 80 | $7,027 | $88 |
| Amitiza | 12 | $5,305 | $442 |
| Linzess | 11 | $3,854 | $350 |
| Nexium | 11 | $2,779 | $253 |
| Omeprazole | 178 | $1,966 | $11 |
| Moviprep | 17 | $1,673 | $98 |
| Pantoprazole | 67 | $872 | $13 |
| Peg 3350-Electrolyte | 50 | $733 | $15 |
| Ranitidine | 53 | $680 | $13 |
| Polyethylene Glycol 3350 | 12 | $211 | $18 |
| Gavilyte-N | 11 | $181 | $16 |
2016: 13 drugs
| Pentasa | 11 | $13,091 | $1,190 |
| Viread | 11 | $8,699 | $791 |
| Suprep | 55 | $4,543 | $83 |
| Dexilant | 19 | $4,496 | $237 |
| Nexium | 11 | $2,777 | $252 |
| Omeprazole | 127 | $1,758 | $14 |
| Moviprep | 12 | $1,049 | $87 |
| Pantoprazole | 67 | $1,030 | $15 |
| Ranitidine | 50 | $811 | $16 |
| Peg 3350-Electrolyte | 50 | $746 | $15 |
| Gavilyte-N | 23 | $406 | $18 |
| Polyethylene Glycol 3350 | 13 | $164 | $13 |
| Nortriptyline | 12 | $78 | $7 |
2015: 10 drugs
| Pentasa | 11 | $11,235 | $1,021 |
| Nexium | 16 | $3,977 | $249 |
| Moviprep | 48 | $3,854 | $80 |
| Omeprazole | 120 | $1,777 | $15 |
| Pantoprazole | 66 | $1,137 | $17 |
| Lansoprazole | 18 | $730 | $41 |
| Peg 3350-Electrolyte | 23 | $380 | $17 |
| Ranitidine | 21 | $316 | $15 |
| Lactulose | 16 | $271 | $17 |
| Gavilyte-N | 12 | $208 | $17 |
2014: 9 drugs
| Nexium | 17 | $5,321 | $313 |
| Lialda | 11 | $3,667 | $333 |
| Moviprep | 37 | $3,007 | $81 |
| Omeprazole | 192 | $2,804 | $15 |
| Lansoprazole | 24 | $2,675 | $111 |
| Pantoprazole | 50 | $1,059 | $21 |
| Ranitidine | 56 | $701 | $13 |
| Baclofen | 13 | $160 | $12 |
| Amitriptyline | 14 | $56 | $4 |
2013: 15 drugs
| Aciphex | 23 | $15,163 | $659 |
| Asacol | 14 | $13,443 | $960 |
| Nexium | 16 | $8,193 | $512 |
| Omeprazole | 302 | $5,580 | $18 |
| Lansoprazole | 32 | $4,744 | $148 |
| Pantoprazole | 114 | $2,807 | $25 |
| Ranitidine | 134 | $1,933 | $14 |
| Moviprep | 20 | $1,449 | $72 |
| Misoprostol | 15 | $1,040 | $69 |
| Peg-3350 With Flavor Packs | 12 | $219 | $18 |
| Dicyclomine | 15 | $179 | $12 |
| Famotidine | 12 | $176 | $15 |
| Baclofen | 18 | $162 | $9 |
| Loperamide | 19 | $156 | $8 |
| Amitriptyline | 19 | $57 | $3 |
Money from drug and device companies
$376 in 2025
| 2025 | 3 | 8 | None | $376 |
| 2023 | 1 | 2 | None | $196 |
| 2022 | 2 | 2 | None | $114 |
| 2021 | 1 | 4 | None | $62 |
| 2019 | 2 | 7 | $4,410 | $5,118 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | None | $296 | 6 payments
|
| Aimmune Therapeutics | Vowst | $66 | 1 payment
|
| Conmed | Conmed Biliary | $14 | 1 payment
|
See all 8 published payments
| Gilead Sciences | Meals · 2025-12-03 | None | $22 |
| Conmed | Meals · 2025-10-04 | Conmed Biliary | $14 |
| Gilead Sciences | Meals · 2025-09-11 | None | $20 |
| Gilead Sciences | Meals · 2025-08-20 | None | $25 |
| Aimmune Therapeutics | Meals · 2025-05-05 | Vowst | $66 |
| Gilead Sciences | Meals · 2025-05-04 | None | $132 |
| Gilead Sciences | Meals · 2025-05-01 | None | $76 |
| Gilead Sciences | Meals · 2025-04-08 | None | $21 |
See earlier years (2023, 2022, 2021, 2019)
2023: $196
| Gilead Sciences | Vemlidy | $196 | 2 payments
|
2022: $114
| Gilead Sciences | None | $92 | 1 payment
|
| PENTAX of America | C2 Cryoballoon | $22 | 1 payment
|
2021: $62
| Gilead Sciences | None | $62 | 4 payments
|
2019: $5,118
| Pfizer | Xeljanz | $5,002 | 4 payments
|
| Gilead Sciences | None | $116 | 3 payments
|
Professional record
- NPI
- 1275682650
- Licence
- CA A94260California A94260: Current · expires 2028-03-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 2004
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 701 E El Camino Real, 1st Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-01-09
- NPI last updated
- 2013-12-12
This is when the NPI record was last certified, not a medical board exam.